The Society for Immunotherapy of Cancer (SITC) hosted Session 208a during the 39th Annual Meeting & Pre-Conference Programs on Saturday, November 9, 2024. Available here are the presentation slides and video from “Session 208a: The Yin and Yang of Myeloid Cells” as permitted by presenters. This session is co-organized by the Society for Immunotherapy of Cancer (SITC) and The Myeloid Network.
Jennifer Guerriero, PhD – Brigham and Women's Hospital
Alberto Mantovani, MD – Instituto Clinico Humanitas
Myeloid cells are a major component of the tumor microenvironment (TME) and can promote tumor progression and resistance to immunotherapy; conversely, they can also contribute to anti-tumor responses. This program will explore the opposing roles (ie the Yin and Yang) of myeloid cells. This program will explore the recent advances in the field including underlying biology and diversity of myeloid cells, myeloid signaling pathways, regulation of myeloid cells and therapeutic approaches to target myeloid cells in immuno-oncology. The session aims to bring the field together to educate and promote myeloid cell targeting with the overall goal of making the TME more permissive and expanding tumor specific T cells. This session is relevant to basic, translational, and clinical researchers and physicians and will provide an overview of the diversity, functions and therapeutic targeting of myeloid cells in cancer.
To view the entire program schedule (including presenter permission to post) please click here.
01:29:52